D3 Bio’s $62 Million Series A Financing Round

Leila Ahmed
Tagged:

Wilson Sonsini Goodrich & Rosati represented the investors in the transaction.D3 Bio, Inc, a clinical-stage biotechnology announced its closing of a $62 million Series A financing round….

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

…

This content is for Standard 1 Year members only.
Login Join Now